在全科医生中,新的口服解凝剂处方决定:谨慎处理
Ann Kirby1, Aileen Murphy1, Colin Bradley2
1Cork University Business School University College Cork, Cork, Ireland.
Journal of health economics and outcomes research
|September 4, 2023
概括
一般医生在为心房处方新的口服抗凝剂 (NOACs) 时考虑患者的风险因素,如和肝功能障碍. 医生特征,如年龄和性别,也会影响这些决定,强调需要教育和仔细选择患者.
科学领域:
- 药理学 药理学是指药理学的学科.
- 一般的做法一般的做法
- 心脏病学 心脏病学
背景情况:
- 华法林是一种传统的口服抗凝剂,由于其狭窄的治疗范围和监测要求,在心房动 (AF) 管理方面存在挑战.
- 新的口服抗凝剂 (NOAC) 提供了替代品,但涉及更高的成本和额外的药理方面的考虑.
- 随着AF药物治疗的不断发展,需要了解影响处方模式的因素.
研究的目的:
- 调查特定的风险因素如何影响全科医生 (GPs) 在为AF患者处方NOAC时的决定.
- 分析功能障碍,肝功能障碍,并发症和药物相互作用对NOAC处方的影响.
- 为了控制GP的特点,了解NOAC的处方行为.
主要方法:
- 利用来自2015年爱尔兰全科医生调查的初级数据.
- 采用多变量探测模型来评估联合决策过程.
- 研究了四个关键风险因素对NOAC处方选择的影响.
主要成果:
- 年轻和男性全科医生在NOAC处方中对并发症和功能障碍的考虑程度更高.
- 男性全科医生也更有可能考虑药物相互作用.
- 开始NOAC的全科医生更倾向于优先考虑功能障碍.
结论:
- 适当的教育,适当的患者选择和监测对于处方NOAC的全科医生至关重要.
- 虽然华法林仍然普遍存在,但NOAC的采用正在增加.
- 将风险因素评估纳入处方决策,有助于对AF患者进行负责任的管理.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
749
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
749
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
560
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
560
Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Rheumatic Heart Disease III: Medical Management
12
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
12


